IL149379A0 - Mimetic peptides for epitope of apolipoprotein b-100, concatemer and modified peptides thereof, and the vaccine composition comprising the same - Google Patents

Mimetic peptides for epitope of apolipoprotein b-100, concatemer and modified peptides thereof, and the vaccine composition comprising the same

Info

Publication number: IL149379A0
Authority: IL; Israel
Prior art keywords: peptides; concatemer; apolipoprotein; epitope; same
Prior art date: 2000-09-04

Application number

IL14937901A

Other languages

English (en)

Original Assignee

Hyo Joon Kim

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-09-04

Filing date

2001-09-04

Publication date

2002-11-10

2001-09-04 Application filed by Hyo Joon Kim filed Critical Hyo Joon Kim

2001-09-04 Priority claimed from KR10-2001-0054005A external-priority patent/KR100472841B1/ko

2002-11-10 Publication of IL149379A0 publication Critical patent/IL149379A0/xx

Links

102000006991 Apolipoprotein B-100 Human genes 0.000 title 1
108010008150 Apolipoprotein B-100 Proteins 0.000 title 1
108091028732 Concatemer Proteins 0.000 title 1
108091005601 modified peptides Proteins 0.000 title 1
102000004196 processed proteins & peptides Human genes 0.000 title 1
108090000765 processed proteins & peptides Proteins 0.000 title 1
229960005486 vaccine Drugs 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/775—Apolipopeptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Zoology (AREA)
Biochemistry (AREA)
Diabetes (AREA)
Hematology (AREA)
Obesity (AREA)
Toxicology (AREA)
Biophysics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Molecular Biology (AREA)
Gastroenterology & Hepatology (AREA)
Genetics & Genomics (AREA)
Child & Adolescent Psychology (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Medicinal Preparation (AREA)

IL14937901A 2000-09-04 2001-09-04 Mimetic peptides for epitope of apolipoprotein b-100, concatemer and modified peptides thereof, and the vaccine composition comprising the same IL149379A0 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
KR20000052055		2000-09-04
PCT/KR2001/001492 WO2002020040A1 (en)	2000-09-04	2001-09-04	Mimetic peptides for epitope of apolipoprotein b-100, concatemer and modified peptides thereof, and the vaccine composition comprising the same
KR10-2001-0054005A KR100472841B1 (ko)	2000-09-04	2001-09-04	아포지단백질 비-100의 에피토프에 대한 모조 펩타이드,그들의 연쇄물 또는 변형체와 이들을 함유하는 백신 조성물

Publications (1)

Publication Number	Publication Date
IL149379A0 true IL149379A0 (en)	2002-11-10

Family

ID=26638363

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL14937901A IL149379A0 (en)	2000-09-04	2001-09-04	Mimetic peptides for epitope of apolipoprotein b-100, concatemer and modified peptides thereof, and the vaccine composition comprising the same

Country Status (18)

Country	Link
US (1)	US6825318B2 (lt)
EP (1)	EP1315517B1 (lt)
JP (1)	JP2004508029A (lt)
CN (1)	CN1231262C (lt)
AU (1)	AU8628601A (lt)
BG (1)	BG106655A (lt)
BR (1)	BR0107175A (lt)
CA (1)	CA2389739A1 (lt)
CZ (1)	CZ20021571A3 (lt)
EE (1)	EE200200238A (lt)
HU (1)	HUP0203251A2 (lt)
IL (1)	IL149379A0 (lt)
LT (1)	LT4989B (lt)
MX (1)	MXPA02004505A (lt)
NO (1)	NO20022147D0 (lt)
RU (1)	RU2313536C2 (lt)
SK (1)	SK6312002A3 (lt)
WO (1)	WO2002020040A1 (lt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2004111225A1 (en) *	2003-06-11	2004-12-23	Schering Aktiengesellschaft	Novel modified corin molecules having substitute activation sequences and uses thereof
KR100639397B1 (ko) *	2004-03-18	2006-10-26	(주)에스제이바이오메드	항비만용 면역원성 하이브리드 폴리펩타이드 및 이를포함하는 항비만 백신 조성물
US20070054298A1 (en) *	2005-08-12	2007-03-08	Kent Kirshenbaum	Methods for enzyme-mediated coupling of oligomers
WO2007075335A2 (en) *	2005-12-16	2007-07-05	The Regents Of The University Of California	Modulation of in utero immune programming
US8961982B2 (en) *	2005-12-16	2015-02-24	The Regents Of The University Of California	Modulation of developmental immune programming and protection against cardiovascular disease, diabetes, infectious diseases, and cancer
MX2009003188A (es) *	2006-09-25	2009-05-22	Sj Biomedic Inc	Polipeptidos hibridos inmunogenicos antiobesidad y composicion de vacuna antiobesidad que comprende los mismos.
CN103520713B (zh) *	2013-10-16	2015-10-28	西北农林科技大学	一种ApoB100酵母重组疫苗及其制备方法和应用
US10858422B2 (en)	2016-05-31	2020-12-08	Abcentra, Llc	Methods for treating systemic lupus erythematosus with an anti-apolipoprotein B antibody
EP3463416A1 (en)	2016-05-31	2019-04-10	CardioVax, LLC	Methods for diagnosing and treating systemic lupus erythematosus

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3215310A1 (de) *	1982-04-23	1983-10-27	Boehringer Mannheim Gmbh, 6800 Mannheim	Verfahren zur bestimmung der low density lipoproteine (ldl) und reagenz zu seiner durchfuehrung
US6309853B1 (en) *	1994-08-17	2001-10-30	The Rockfeller University	Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof
WO1998039469A1 (en) *	1997-03-04	1998-09-11	Bio-Technology General Corp.	Isolation of tissue specific peptide ligands and their use for targeting pharmaceuticals to organs
WO1999045020A1 (en) *	1998-03-04	1999-09-10	Bio-Technology General Corp.	Isolation of tissue specific peptide ligands and their use for targeting pharmaceuticals to organs
WO2001064008A2 (en) *	2000-03-03	2001-09-07	Smithkline Beecham Biologicals S.A.	Vaccine for the treatment of artherosclerosis

2001
- 2001-09-04 EE EEP200200238A patent/EE200200238A/xx unknown
- 2001-09-04 HU HU0203251A patent/HUP0203251A2/hu unknown
- 2001-09-04 CA CA002389739A patent/CA2389739A1/en not_active Abandoned
- 2001-09-04 EP EP01965715A patent/EP1315517B1/en not_active Expired - Lifetime
- 2001-09-04 WO PCT/KR2001/001492 patent/WO2002020040A1/en not_active Ceased
- 2001-09-04 RU RU2003109439/13A patent/RU2313536C2/ru not_active IP Right Cessation
- 2001-09-04 CZ CZ20021571A patent/CZ20021571A3/cs unknown
- 2001-09-04 CN CNB018030572A patent/CN1231262C/zh not_active Expired - Fee Related
- 2001-09-04 BR BR0107175-0A patent/BR0107175A/pt not_active Application Discontinuation
- 2001-09-04 IL IL14937901A patent/IL149379A0/xx unknown
- 2001-09-04 MX MXPA02004505A patent/MXPA02004505A/es unknown
- 2001-09-04 JP JP2002524523A patent/JP2004508029A/ja active Pending
- 2001-09-04 SK SK631-2002A patent/SK6312002A3/sk unknown
- 2001-09-04 AU AU86286/01A patent/AU8628601A/en not_active Abandoned
2002
- 2002-04-25 BG BG106655A patent/BG106655A/bg unknown
- 2002-04-29 LT LT2002051A patent/LT4989B/lt not_active IP Right Cessation
- 2002-05-03 NO NO20022147A patent/NO20022147D0/no not_active Application Discontinuation
2003
- 2003-03-04 US US10/378,707 patent/US6825318B2/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
NO20022147L (no)	2002-05-03
WO2002020040A1 (en)	2002-03-14
US6825318B2 (en)	2004-11-30
LT4989B (lt)	2003-01-27
CN1231262C (zh)	2005-12-14
NO20022147D0 (no)	2002-05-03
MXPA02004505A (es)	2004-09-10
EP1315517B1 (en)	2010-10-20
SK6312002A3 (en)	2002-09-10
RU2003109439A (ru)	2004-07-20
RU2313536C2 (ru)	2007-12-27
AU8628601A (en)	2002-03-22
HUP0203251A2 (hu)	2003-01-28
BG106655A (bg)	2004-08-31
JP2004508029A (ja)	2004-03-18
CZ20021571A3 (cs)	2002-09-11
CN1392798A (zh)	2003-01-22
BR0107175A (pt)	2002-07-02
EE200200238A (et)	2003-06-16
EP1315517A1 (en)	2003-06-04
US20030211997A1 (en)	2003-11-13
LT2002051A (lt)	2002-09-25
EP1315517A4 (en)	2005-02-09
CA2389739A1 (en)	2002-03-14

Publication	Publication Date	Title
AU5943201A (en)	2001-11-12	Modified peptides as therapeutic agents
AU8079901A (en)	2002-02-13	Promyostatin peptides and methods of using same
IL155842A0 (en)	2003-12-23	Diaryl peptides as ns3-serine protease inhibitors of hepatitis c virus
HUP0300099A3 (en)	2004-10-28	Vaccine for the treatment of artherosclerosis
HU229997B1 (en)	2015-04-28	Peptides as ns3-serine protease inhibitors of hepatitis c virus
IL143633A0 (en)	2002-04-21	Peptides containing ovarian carcinoma proteins and pharmaceutical compositions and vaccines containing the same
AU2001286730A1 (en)	2002-03-04	An iap binding peptide or polypeptide and methods of using the same
IL149379A0 (en)	2002-11-10	Mimetic peptides for epitope of apolipoprotein b-100, concatemer and modified peptides thereof, and the vaccine composition comprising the same
AU2524702A (en)	2002-04-22	The caveolin-1 gene and polypeptide encoded thereby and methods of use thereof
EP1419175A4 (en)	2006-07-19	PEPTIDES OF REPLIKIN AND THEIR USE
AUPQ712000A0 (en)	2000-05-18	Antigenic peptide fragments of VapA protein, and uses thereof
AU8542701A (en)	2002-02-18	Stress proteins and peptides and methods of use thereof
AU2002217863A1 (en)	2002-06-11	Homing peptide multimers, their preparation and uses
HUP0400737A3 (en)	2013-06-28	Use of l-carnitine for preparation of compositions for stabilizing the proteins
IL150458A0 (en)	2002-12-01	Novel haptotactic peptides
WO2006090090A3 (fr)	2006-12-07	Epitopes de vih et composition pharmaceutique les contenant
GB0030309D0 (en)	2001-01-24	Antibodies,Peptides,Analogs and uses thereof
GB0217327D0 (en)	2002-09-04	Peptide fragments of colostrinin and their use
EP1569677A4 (en)	2008-05-28	LIPOSOMAL COMPOSITION COMPRISING HAPTOTACTIC PEPTIDES
AU2001271281A1 (en)	2001-12-11	Novel compositions for the expression of the human peptide histidine transporter1 and methods of use thereof
WO2000042063A3 (de)	2000-12-14	Peptide zur inhibierung von hbv-core-proteinen
IL135442A0 (en)	2001-05-20	Peptides and pharmaceutical compositions comprising them
GB0108752D0 (en)	2001-05-30	Peptide epitopes and uses thereof
AU8557801A (en)	2002-03-13	Modified proteins, isolated novel peptides, and uses thereof
EP1434874A4 (en)	2005-11-30	IMMUNOAFFINITY ISOLATION OF MODIFIED PEPTIDES FROM COMPLEX MIXTURES